Compare FDMT & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | CLDT |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 660.3M |
| IPO Year | 2019 | 2009 |
| Metric | FDMT | CLDT |
|---|---|---|
| Price | $10.21 | $15.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $28.09 | $16.17 |
| AVG Volume (30 Days) | ★ 855.5K | 444.7K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | 18.79 | ★ 275.00 |
| EPS | N/A | ★ 0.11 |
| Revenue | $85,209,000.00 | ★ $295,075,000.00 |
| Revenue This Year | N/A | $9.69 |
| Revenue Next Year | $20.79 | $3.41 |
| P/E Ratio | ★ N/A | $140.64 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $6.96 | $6.41 |
| 52 Week High | $16.93 | $16.61 |
| Indicator | FDMT | CLDT |
|---|---|---|
| Relative Strength Index (RSI) | 37.51 | 53.94 |
| Support Level | $8.43 | $12.36 |
| Resistance Level | $10.61 | $16.61 |
| Average True Range (ATR) | 0.85 | 0.57 |
| MACD | -0.15 | -0.08 |
| Stochastic Oscillator | 1.07 | 32.97 |
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.